C. Ola Landgren, MD, PhD, on Managing a Complex Four-Agent Regimen in Myeloma

Posted: Thursday, January 2, 2020

C. Ola Landgren, MD, PhD, of Memorial Sloan Kettering Cancer Center, talks about the challenges of administering a complex regimen of oral and infused drugs, in varying doses throughout the cycle, for multiple myeloma.